Sanchez-Carro, Y, de la Torre-Luque, A, Portella, MJ, Leal-Leturia, I, Salvat-Pujol, N, Massaneda, C, de Arriba-Arnau, A, Urretavizcaya, M, Pereto, M, Toll, A, Martinez-Ruiz, A, Ferreiros-Martinez, R, Alvarez, P, Soria, V, Lopez-Garcia, P. Relationship between immunometabolic status and cognitive performance among major depression disorder patients. PSYCHONEUROENDOCRINOLOGY. 2022; 137DOI:10.1016/j.psyneuen.2021.105631. PMID:34929555. IF:3.700(Q2/5D).

Ferrer-Quintero, M, Fernandez, D, Lopez-Carrilero, R, Birules, I, Barajas, A, Lorente-Rovira, E, Diaz-Cutraro, L, Verdaguer, M, Garcia-Mieres, H, Sevilla-Llewellyn-Jones, J, Gutierrez-Zotes, A, Grasa, E, Pousa, E, Huerta-Ramos, E, Pelaez, T, Barrigon, ML, Gonzalez-Higueras, F, Ruiz-Delgado, I, Cid, J, Moritz, S, Ochoa, S. Persons with first episode psychosis have distinct profiles of social cognition and metacognition (vol 9, 61, 2021). SCHIZOPHRENIA. 2022; 8(1)DOI:10.1038/s41537-021-00199-4. PMID:35210466. IF:5.400(Q2/3D).

Amoretti, S, Rosa, AR, Mezquida, G, Cabrera, B, Ribeiro, M, Molina, M, Bioque, M, Lobo, A, Gonzalez-Pinto, A, Fraguas, D, Corripio, I, Vieta, E, de la Serna, E, Morro, L, Garriga, M, Torrent, C, Cuesta, MJ, Bernardo, M, PEPs Grp. The impact of cognitive reserve, cognition and clinical symptoms on psychosocial functioning in first-episode psychoses. PSYCHOLOGICAL MEDICINE. 2022; 52(3)DOI:10.1017/S0033291720002226. PMID:32900395. IF:6.900(Q1/1D).

Baenas, I, Etxandi, M, Munguia, L, Granero, R, Mestre-Bach, G, Sanchez, I, Ortega, E, Andreu, A, Moize, VL, Fernandez-Real, JM, Tinahones, FJ, Dieguez, C, Fruhbeck, G, Le Grange, D, Tchanturia, K, Karwautz, A, Zeiler, M, Imgart, H, Zanko, A, Favaro, A, Claes, L, Shekriladze, I, Serrano-Troncoso, E, Cecilia-Costa, R, Rangil, T, Loran-Meler, ME, Soriano-Pacheco, J, Carceller-Sindreu, M, Navarrete, R, Lozano, M, Linares, R, Gudiol, C, Carratala, J, Plana, MT, Graell, M, Gonzalez-Parra, D, Gomez-del Barrio, JA, Sepulveda, AR, Sanchez-Gonzalez, J, Machado, PPP, Hakansson, A, Tury, F, Paszthy, B, Stein, D, Papezova, H, Gricova, J, Bax, B, Borisenkov, MF, Popov, SV, Gubin, DG, Petrov, IM, Isakova, D, Mustafina, SV, Kim, YR, Nakazato, M, Godart, N, van Voren, R, Ilnytska, T, Chen, J, Rowlands, K, Voderholzer, U, Monteleone, AM, Treasure, J, Jimenez-Murcia, S, Fernandez-Aranda, F. Impact of COVID-19 Lockdown in Eating Disorders: A Multicentre Collaborative International Study. Nutrients. 2022; 14(1)DOI:10.3390/nu14010100. PMID:35010974. IF:5.900(Q1/2D).

Caso, JR, MacDowell, KS, Gonzalez-Pinto, A, Garcia, S, de Diego-Adelino, J, Carceller-Sindreu, M, Sarramea, F, Caballero-Villarraso, J, Gracia-Garcia, P, De la Camara, C, Aguera, L, Gomez-Lus, ML, Alba, C, Rodriguez, JM, Leza, JC. Gut microbiota, innate immune pathways, and inflammatory control mechanisms in patients with major depressive disorder. Translational Psychiatry. 2021; 11(1)DOI:10.1038/s41398-021-01755-3. PMID:34934041. IF:7.989(Q1/2D).

Roberto, N, Portella, MJ, Marquie, M, Alegret, M, Hernandez, I, Mauleon, A, Rosende-Roca, M, Abdelnour, C, de Antonio, EE, Tartari, JP, Vargas, L, Lopez-Cuevas, R, Bojaryn, U, Espinosa, A, Ortega, G, Perez-Cordon, A, Sanabria, A, Orellana, A, de Rojas, I, Moreno-Grau, S, Montrreal, L, Alarcon-Martin, E, Ruiz, A, Tarraga, L, Boada, M, Valero, S. Neuropsychiatric Profile as a Predictor of Cognitive Decline in Mild Cognitive Impairment. Frontiers in Aging Neuroscience. 2021; 13DOI:10.3389/fnagi.2021.718949. PMID:34955804. IF:5.702(Q1/3D).

Baeza, I, de la Serna, E, Amoretti, S, Cuesta, MJ, Diaz-Caneja, CM, Mezquida, G, Lobo, A, Gonzalez-Pinto, A, Corripio, I, Vieta, E, Puig, O, Legido, T, Bioque, M, Garcia-Rizo, C, Bernardo, M, Castro-Fornieles, J. Premorbid Characteristics as Predictors of Early Onset Versus Adult Onset in Patients With a First Episode of Psychosis. JOURNAL OF CLINICAL PSYCHIATRY. 2021; 82(6)DOI:10.4088/JCP.21m13907. PMID:34529899. IF:5.906(Q2/3D).

Vicent-Gil, M, Serra-Blasco, M, Navarra-Ventura, G, Trujols, J, Balanza-Martinez, V, Portella, MJ, Cardoner, N. In pursuit of full recovery in major depressive disorder. EUROPEAN ARCHIVES OF PSYCHIATRY AND CLINICAL NEUROSCIENCE. 2023; 273(5)DOI:10.1007/s00406-022-01487-5. PMID:36085532. IF:3.500(Q1/3D).

Segura, AG, Mezquida, G, Martinez-Pinteno, A, Gasso, P, Rodriguez, N, Moreno-Izco, L, Amoretti, S, Bioque, M, Lobo, A, Gonzalez-Pinto, A, Garcia-Alcon, A, Roldan-Bejarano, A, Vieta, E, de la Serna, E, Toll, A, Cuesta, MJ, Mas, S, Bernardo, M. Link between cognitive polygenic risk scores and clinical progression after a first-psychotic episode. PSYCHOLOGICAL MEDICINE. 2023; 53(10)DOI:10.1017/S0033291722001544. PMID:35678455. IF:5.900(Q1/1D).

Bioque, M, Matias-Martins, AC, Llorca-Bofi, V, Mezquida, G, Cuesta, MJ, Vieta, E, Amoretti, S, Lobo, A, Gonzalez-Pinto, A, Moreno, C, Roldan, A, Martinez-Aran, A, Baeza, I, Berge, D, Garcia-Rizo, C, Herrero, SM, Bernardo, M. Neutrophil to Lymphocyte Ratio in Patients With a First Episode of Psychosis: A Two-Year Longitudinal Follow-up Study. SCHIZOPHRENIA BULLETIN. 2022; 48(6)DOI:10.1093/schbul/sbac089. PMID:35876785. IF:6.600(Q1/3D).

Montanes-Masias, B, Bort-Roig, J, Pascual, JC, Soler, J, Briones-Buixassa, L. Online psychological interventions to improve symptoms in multiple sclerosis: A systematic review. ACTA NEUROLOGICA SCANDINAVICA. 2022; 146(5)DOI:10.1111/ane.13709. PMID:36121184. IF:3.500(Q2/5D).

Ferrer-Quintero, M, Fernandez, D, Lopez-Carrilero, R, Diaz-Cutraro, L, Verdaguer-Rodriguez, M, Garcia-Mieres, H, Huerta-Ramos, E, Gomez-Benito, J, Pelaez, T, Birules, I, Barajas, A, Pousa, E, Barrigon, M, Gutierrez-Zotes, A, Grasa, E, Ruiz-Delgado, I, Lorente-Rovira, E, Cid, J, Ochoa, S. Heterogeneity in Response to MCT and Psychoeducation: A Feasibility Study Using Latent Class Mixed Models in First-Episode Psychosis. Healthcare. 2022; 10(11)DOI:10.3390/healthcare10112155. PMID:36360496. IF:2.800(Q3/6D).

Serra-Navarro, M, Amoretti, S, Verdolini, N, Forte, MF, Sanchez-Torres, AM, Vieta, E, Clougher, D, Lobo, A, Gonzalez-Pinto, A, Panadero, R, Roldan, A, Carvalho, AF, de la Serna, E, Toll, A, Ramos-Quiroga, JA, Torrent, C, Cuesta, MJ, Bernardo, M. Influence of clinical and neurocognitive factors in psychosocial functioning after a first episode non-affective psychosis: Differences between males and females. Frontiers in Psychiatry. 2022; 13DOI:10.3389/fpsyt.2022.982583. PMID:36339856. IF:4.700(Q2/4D).

Ferrer-Quintero, M, Fernandez, D, Lopez-Carrilero, R, Birules, I, Barajas, A, Lorente-Rovira, E, Luengo, A, Diaz-Cutraro, L, Verdaguer, M, Garcia-Mieres, H, Gutierrez-Zotes, A, Grasa, E, Pousa, E, Huerta-Ramos, E, Pelaez, T, Barrigon, ML, Gomez-Benito, J, Gonzalez-Higueras, F, Ruiz-Delgado, I, Cid, J, Moritz, S, Sevilla-Llewellyn-Jones, J, Ochoa, S. Males and females with first episode psychosis present distinct profiles of social cognition and metacognition. EUROPEAN ARCHIVES OF PSYCHIATRY AND CLINICAL NEUROSCIENCE. 2022; 272(7)DOI:10.1007/s00406-022-01438-0. PMID:35802165. IF:4.700(Q1/3D).

Fouche, JP, Groenewold, NA, Sevenoaks, T, Heany, S, Lochner, C, Alonso, P, Batistuzzo, MC, Cardoner, N, Ching, CRK, de Wit, SJ, Gutman, B, Hoexter, MQ, Jahanshad, N, Kim, M, Kwon, JS, Mataix-Cols, D, Menchon, JM, Miguel, EC, Nakamae, T, Phillips, ML, Pujol, J, Sakai, Y, Yun, JY, Soriano-Mas, C, Thompson, PM, Yamada, K, Veltman, DJ, van den Heuvel, OA, Stein, DJ. Shape analysis of subcortical structures in obsessive-compulsive disorder and the relationship with comorbid anxiety, depression, and medication use: A meta-analysis by the OCD Brain Imaging Consortium. Brain and Behavior. 2022; 12(10)DOI:10.1002/brb3.2755. PMID:36106505. IF:3.100(Q2/3D).

Pousa, E, Brebion, G, Lopez-Carrilero, R, Ruiz, AI, Grasa, E, Barajas, A, Pelaez, T, Alfonso-Gutierrrez-Zotes, Lorente, E, Barrigon, ML, Ruiz-Delgado, I, Gonzalez-Higueras, F, Cid, J, Perez-Sola, V, Ochoa, S. Clinical insight in first-episode psychosis: Clinical, neurocognitive and metacognitive predictors. SCHIZOPHRENIA RESEARCH. 2022; 248DOI:10.1016/j.schres.2022.08.007. PMID:36063607. IF:4.500(Q2/4D).

Montejo, L, Sole, B, Jimenez, E, Borras, R, Clougher, D, Reinares, M, Portella, MJ, Martinez-Aran, A, Vieta, E, Bonnin, CD, Torrent, C. Aging in bipolar disorder: Cognitive performance and clinical factors based on an adulthood-lifespan perspective. JOURNAL OF AFFECTIVE DISORDERS. 2022; 312DOI:10.1016/j.jad.2022.06.030. PMID:35752219. IF:6.600(Q1/2D).

Vicent-Gil M., González-Simarro S., Raventós B., Vera J., Marín Martínez E.D., Sabaté-Cao C., Pérez-Blanco J., Puigdemont D., de Diego-Adeliño J., Alemany C., Serra-Blasco M., Cardoner N., Portella M.J.. Randomized clinical trial of integral cognitive remediation program for major depression (INCREM). JOURNAL OF AFFECTIVE DISORDERS. 2022; 310DOI:10.1016/j.jad.2022.05.016. PMID:35545155. IF:6.600(Q1/2D).

Trujols, J, Duran-Sindreu, S, Portella, MJ. Patient-reported outcome measures (PROMs) to guide clinical care: recommendations and challenges. MEDICAL JOURNAL OF AUSTRALIA. 2022; 217(2)DOI:10.5694/mja2.51614. PMID:35753958. IF:11.400(Q1/2D).

Sánchez-Torres A.M., Peralta V., Gil-Berrozpe G.J., Mezquida G., Ribeiro M., Molina-García M., Amoretti S., Lobo A., González-Pinto A., Merchán-Naranjo J., Corripio I., Vieta E., de la Serna E., Bergé D., Bernardo M., Cuesta M.J., Cabrera B., Pons M., Abregú-Crespo R., Rapado-Castro M., Alonso-Solís A., Grasa E., González-Ortega I., Alberich S., de la Cámara C., Saz P., Aguilar E.J., Escartí M.J., Martínez L., Toll A., Gavin P., Varo C., Baeza I., Puig O., Contreras F., Saiz-Masvidal C., Álvarez L.G., Bascarán M.T.B., Fraile M.G., Rabadán A.Z., Sanchez-Pastor L., Rodriguez-Jimenez R., Usall J., Butjosa A., Sarró S., Landín-Romero R., Ibáñez Á., Moreno-Izco L., Balanzá-Martínez V.. The network structure of cognitive deficits in first episode psychosis patients. SCHIZOPHRENIA RESEARCH. 2022; 244DOI:10.1016/j.schres.2022.05.005. PMID:35594732. IF:4.500(Q2/4D).

Segura, AG, Martinez-Pinteno, A, Gasso, P, Rodriguez, N, Bioque, M, Cuesta, MJ, Gonzalez-Penas, J, Garcia-Rizo, C, Lobo, A, Gonzalez-Pinto, A, Garcia-Alcon, A, Roldan, A, Vista, E, Castro-Fornieles, J, Mane, A, Saiz, J, Bernardo, M, Mas, S. Metabolic polygenic risk scores effect on antipsychotic-induced metabolic dysregulation: A longitudinal study in a first episode psychosis cohort. SCHIZOPHRENIA RESEARCH. 2022; 244DOI:10.1016/j.schres.2022.05.021. PMID:35659654. IF:4.500(Q2/4D).

Alvear, D, Soler, J, Cebolla, A. Meditators' Non-academic Definition of Mindfulness. Mindfulness. 2022; 13(6)DOI:10.1007/s12671-022-01899-3. PMID:35634214. IF:3.600(Q2/4D).

Bioque, M, Mezquida, G, Amoretti, S, Garcia-Rizo, C, Lopez-Ilundain, JM, Diaz-Caneja, CM, Zorrilla, I, Mane, A, Rodriguez-Jimenez, R, Corripio, I, Pomarol-Clotet, E, Ibanez, A, Usall, J, Contreras, F, Mas, S, Vazquez-Bourgon, J, Cuesta, MJ, Parellada, M, Gonzalez-Pinto, A, Hidalgo-Figueroa, M, Bernardo, M. Clinical and treatment predictors of relapse during a three-year follow-up of a cohort of first episodes of schizophrenia. SCHIZOPHRENIA RESEARCH. 2022; 243DOI:10.1016/j.schres.2022.02.026. PMID:35231832. IF:4.500(Q2/4D).

Porta-Casteras, D, Cano, M, Steward, T, Andero, R, Cardoner, N. The pituitary adenylate cyclase-activating polypeptide system as a sex-specific modulator of hippocampal response to threat stimuli. Neurobiology of Stress. 2022; 18DOI:10.1016/j.ynstr.2022.100448. PMID:35685680. IF:5.000(Q2/3D).

Rodriguez, N, Gasso, P, Martinez-Pinteno, A, Segura, AG, Mezquida, G, Moreno-Izco, L, Gonzalez-Penas, J, Zorrilla, I, Martin, M, Rodriguez-Jimenez, R, Corripio, I, Sarro, S, Ibanez, A, Butjosa, A, Contreras, F, Bioque, M, Cuesta, MJ, Parellada, M, Gonzalez-Pinto, A, Berrocoso, E, Bernardo, M, Mas, S, Amoretti, SS, Moren, C, Stella, C, Gurriaran, X, Alonso-Solis, A, Grasa, E, Fernandez, J, Gonzalez-Ortega, I, Casanovas, F, Bulbuena, A, Nunez-Doyle, A, Jimenez-Rodriguez, O, Pomarol-Clotet, E, Feria-Raposo, I, Usall, J, Munoz-Samons, D, Ilundain, JL, Sanchez-Torres, AM, Saiz-Ruiz, J, Lopez-Torres, I, Nacher, J, De-la-Camara, C, Gutierrez, M, Saiz, PA. Gene co-expression architecture in peripheral blood in a cohort of remitted first-episode schizophrenia patients. SCHIZOPHRENIA. 2022; 8(1)DOI:10.1038/s41537-022-00215-1. PMID:35853879. IF:5.400(Q2/3D).

Martínez-Pinteño A., Mezquida G., Bioque M., López-Ilundain J.M., Andreu-Bernabeu Á., Zorrilla I., Mané A., Rodríguez-Jiménez R., Corripio I., Sarró S., Ibáñez Á., Usall J., Rivero O., Gassó P., Leza J.C., Cuesta M.J., Parellada M., González-Pinto A., Berrocoso E., Mas S., Bernardo M., Amoretti S., Morén C., Urbiola E., González-Peñas J., Roldán A., Catalán A., González-Ortega I., Toll A., Legido T., Sanchez-Pastor L., Dompablo M., Pomarol-Clotet E., R L.-R., Butjosa A., Rubio E., Lorente-OmeñacaR, Ribeiro M., López-Torres I., León-Quismondo L., Nácher J., Contretas F., Lobo A., Gutiérrez-Fraile M., Sáiz P.A.. The role of BDNF and NGF plasma levels in first-episode schizophrenia: A longitudinal study. EUROPEAN NEUROPSYCHOPHARMACOLOGY. 2022; 57DOI:10.1016/j.euroneuro.2022.02.003. PMID:35219096. IF:5.600(Q1/2D).

Wierenga L.M., Doucet G.E., Dima D., Agartz I., Aghajani M., Akudjedu T.N., Albajes-Eizagirre A., Alnæs D., Alpert K.I., Andreassen O.A., Anticevic A., Asherson P., Banaschewski T., Bargallo N., Baumeister S., Baur-Streubel R., Bertolino A., Bonvino A., Boomsma D.I., Borgwardt S., Bourque J., den Braber A., Brandeis D., Breier A., Brodaty H., Brouwer R.M., Buitelaar J.K., Busatto G.F., Calhoun V.D., Canales-Rodríguez E.J., Cannon D.M., Caseras X., Castellanos F.X., Chaim-Avancini T.M., Ching C.R.K., Clark V.P., Conrod P.J., Conzelmann A., Crivello F., Davey C.G., Dickie E.W., Ehrlich S., van't Ent D., Fisher S.E., Fouche J.-P., Franke B., Fuentes-Claramonte P., de Geus E.J.C., Giorgio A.D., Glahn D.C., Gotlib I.H., Grabe H.J., Gruber O., Gruner P., Gur R.E., Gur R.C., Gurholt T.P., de Haan L., Haatveit B., Harrison B.J., Hartman C.A., Hatton S.N., Heslenfeld D.J., van den Heuvel O.A., Hickie I.B., Hoekstra P.J., Hohmann S., Holmes A.J., Hoogman M., Hosten N., Howells F.M., Hulshoff Pol H.E., Huyser C., Jahanshad N., James A.C., Jiang J., Jönsson E.G., Joska J.A., Kalnin A.J., Klein M., Koenders L., Kolskår K.K., Krämer B., Kuntsi J., Lagopoulos J., Lazaro L., Lebedeva I.S., Lee P.H., Lochner C., Machielsen M.W.J., Maingault S., Martin N.G., Martínez-Zalacaín I., Mataix-Cols D., Mazoyer B., McDonald B.C., McDonald C., McIntosh A.M., McMahon K.L., McPhilemy G., van der Meer D., Menchón J.M., Naaijen J., Nyberg L., Oosterlaan J., Paloyelis Y., Pauli P., Pergola G., Pomarol-Clotet E., Portella M.J., Radua J., Reif A., Richard G., Roffman J.L., Rosa P.G.P., Sacchet M.D., Sachdev P.S., Salvador R., Sarró S., Satterthwaite T.D., Saykin A.J., Serpa M.H., Sim K., Simmons A., Smoller J.W., Sommer I.E., Soriano-Mas C., Stein D.J., Strike L.T., Szeszko P.R., Temmingh H.S., Thomopoulos S.I., Tomyshev A.S., Trollor J.N., Uhlmann A., Veer I.M., Veltman D.J., Voineskos A., Völzke H., Walter H., Wang L., Wang Y., Weber B., Wen W., West J.D., Westlye L.T., Whalley H.C., Williams S.C.R., Wittfeld K., Wolf D.H., Wright M.J., Yoncheva Y.N., Zanetti M.V., Ziegler G.C., de Zubicaray G.I., Thompson P.M., Crone E.A., Frangou S., Tamnes C.K.. Greater male than female variability in regional brain structure across the lifespan. HUMAN BRAIN MAPPING. 2022; 43(1)DOI:10.1002/hbm.25204. PMID:33044802. IF:4.800(Q1/2D).

Lorente-Rovira E., Grasa E., Ochoa S., Corripio I., Peláez T., López-Carrilero R., Gutiérrez-Gea Á., Morano-Guillén M., Villagrán J.M., Bartels-Velthuis A.A., Jenner J.A., Sanjuán J.. Different measures for auditory hallucinations in populations with psychosis. The Validation of the Spanish versions of the Auditory Vocal Hallucination Rating Scale (AVHRS) and the Positive and Useful Voices Inquiry (PUVI). SPANISH JOURNAL OF PSYCHIATRY AND MENTAL HEALTH. 2022; 15(4)DOI:10.1016/j.rpsm.2020.03.002. PMID:32493672. IF:9.200(Q1/1D).

Perez-Rando, M, Elvira, UKA, Garcia-Marti, G, Gadea, M, Aguilar, EJ, Escarti, MJ, Ahullo-Fuster, MA, Grasa, E, Corripio, I, Sanjuan, J, Nacher, J. Alterations in the volume of thalamic nuclei in patients with schizophrenia and persistent auditory hallucinations. NeuroImage-Clinical. 2022; 35DOI:10.1016/j.nicl.2022.103070. PMID:35667173. IF:4.200(Q2/3D).

Safont G., Garriga M., Amoretti S., Cuesta M.J., Parellada M., González-Pinto A., Bergé D., Rodriguez-Jimenez R., Bejarano A.R., Sarró S., Ibáñez Á., Usall J., Gutiérrez M., Vieta E., Arranz B., Berrocoso E., Verdolini N., Bernardo M.. Sex and substance use in first episode psychosis: Impact on clinical symptoms, psychosocial functioning and cognitive performance. SPANISH JOURNAL OF PSYCHIATRY AND MENTAL HEALTH. 2025; 18(2)DOI:10.1016/j.rpsm.2022.03.002. PMID:. IF:2.800(Q2/4D).

Espinosa, V, Bagaeva, A, Lopez-Carrilero, R, Barajas, A, Barrigón, ML, Birulés, I, Frigola-Capell, E, Díaz-Cutraro, L, González-Higueras, F, Grasa, E, Gutiérrez-Zotes, A, Lorente-Rovira, E, Pélaez, T, Pousa, E, Ruiz-Delgado, I, Verdaguer-Rodríguez, M, Ochoa, S. Neuropsychological profiles in first-episodes psychosis and their relationship with clinical, metacognition and social cognition variables. EUROPEAN ARCHIVES OF PSYCHIATRY AND CLINICAL NEUROSCIENCE. 2025; 275(3)DOI:10.1007/s00406-024-01813-z. PMID:38806850. IF:3.700(Q1/3D).

Miquel-Giner N., Vicent-Gil M., Martínez-Zalacaín I., Porta-Casteras D., Mar L., López-Solà M., Andrews-Hanna J.R., Soriano-Mas C., Menchón J.M., Cardoner N., Alonso P., Serra-Blasco M., López-Solà C.. Efficacy and fMRI-based response predictors to mindfulness-based cognitive therapy in obsessive-compulsive disorder: Study protocol for a randomised clinical trial. SPANISH JOURNAL OF PSYCHIATRY AND MENTAL HEALTH. 2025; 18(1)DOI:10.1016/j.rpsm.2022.11.002. PMID:37839958. IF:2.800(Q1/1D).

Soler, J, Otero, D, Elices, M, Farres, CC, Vera, J, Pascual, JC. Exploring direct experience as a core element behind mindfulness-based cognitive therapy. EUROPEAN JOURNAL OF PSYCHIATRY. 2024; 38(4)DOI:10.1016/j.ejpsy.2024.100268. PMID:. IF:1.500(Q3/7D).

Pousa, E, Brébion, G, López-Carrilero, R, Ruiz, AI, Grasa, E, Barajas, A, Cobo, J, Gutiérrez-Zotes, A, Lorente, E, Barrigón, ML, Ruiz-Delgado, I, González-Higueras, F, Frigola-Capell, E, Ochoa, S. Predictors of clinical insight in first-episode psychosis: Different patterns in men and women. PSYCHIATRY RESEARCH. 2024; 339DOI:10.1016/j.psychres.2024.116036. PMID:38964140. IF:3.900(Q1/2D).

González-Saiz, F, Vergara-Moragues, E, Trujols, J, Alcaraz, S, de los Cobos, JP. Assessing predictors of adequate individual buprenorphine maintenance dosage for the treatment of opioid use disorder: Listening to the patient. INTERNATIONAL JOURNAL OF DRUG POLICY. 2024; 130DOI:10.1016/j.drugpo.2024.104519. PMID:39024687. IF:4.400(Q1/1D).

Clougher, D, Forte, MF, Mezquida, G, Sánchez-Torres, AM, Serra-Navarro, M, Penadés, R, Lobo, A, Pinto, AG, Panadero, R, Roldán, A, Vieta, E, de la Serna, E, Trabsa, A, Martínez-Aran, A, Torrent, C, Tortorella, A, Menculini, G, Ramos-Quiroga, JA, Cuesta, MJ, Bernardo, M, Amoretti, S. Emotional intelligence and neurocognition profiles in first-episode psychosis: A two-year follow-up study. EUROPEAN NEUROPSYCHOPHARMACOLOGY. 2024; 85DOI:10.1016/j.euroneuro.2024.05.006. PMID:39013243. IF:6.700(Q1/1D).

Corripio, I, Fraguas, D, García-Portilla, MP, Olivares, JM, Sierra, P, Sánchez, P. Functioning in schizophrenia: Recommendations of an expert panel. SCHIZOPHRENIA RESEARCH. 2024; 270DOI:10.1016/j.schres.2024.06.050. PMID:38964076. IF:3.500(Q1/3D).

Florido, A, Velasco, ER, Romero, LR, Acharya, N, Blasco, IJM, Nabás, JF, Perez-Caballero, L, Rivero, G, Olabarrieta, E, Nuñez-delMoral, A, González-Parra, JA, Porta-Casteràs, D, Cano, M, Steward, T, Antony, MS, Cardoner, N, Torrubia, R, Jackson, AC, Fullana, MA, Andero, R. Sex differences in neural projections of fear memory processing in mice and humans. Science Advances. 2024; 10(28)DOI:10.1126/sciadv.adk3365. PMID:38985873. IF:12.500(Q1/1D).

Porta-Casteràs, D, Vicent-Gil, M, Serra-Blasco, M, Navarra-Ventura, G, Solé, B, Montejo, L, Torrent, C, Martinez-Aran, A, de la Peña-Arteaga, V, Palao, D, Vieta, E, Cardoner, N, Cano, M. Increased grey matter volumes in the temporal lobe and its relationship with cognitive functioning in euthymic patients with bipolar disorder. PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY. 2024; 132DOI:10.1016/j.pnpbp.2024.110962. PMID:38365103. IF:3.900(Q1/2D).

Camacho-Téllez, V, Castro, MN, Wainsztein, AE, Goldberg, X, De Pino, G, Costanzo, EY, Cardoner, N, Menchón, JM, Soriano-Mas, C, Guinjoan, SM, Villarreal, MF. Childhood adversity modulates structural brain changes in borderline personality but not in major depression disorder. PSYCHIATRY RESEARCH-NEUROIMAGING. 2024; 340DOI:10.1016/j.pscychresns.2024.111803. PMID:38460393. IF:2.100(Q1/1D).